Related Experiment Video

Updated: Jan 21, 2026

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

7.7K

miR-548d-3p inhibits osteosarcoma by downregulating KRAS

Jianhua Chen1, Chongnan Yan1, Honghao Yu1

  • 1Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang 110001, People's Republic of China.

Aging
|July 23, 2019
PubMed

Insights

MicroRNAs (miRNAs) are linked to osteosarcoma. Lower miR-548d-3p levels in tumors suggest it suppresses growth by targeting KRAS, indicating potential therapeutic use.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) play crucial roles in cancer development.
  • Osteosarcoma, a primary bone cancer, exhibits altered miRNA expression profiles.
  • Specific miRNAs are being investigated for their potential as diagnostic and therapeutic targets in osteosarcoma.

Purpose of the Study:

  • To investigate the role of miR-548d-3p in osteosarcoma.
  • To identify potential target genes of miR-548d-3p in osteosarcoma cells.
  • To evaluate the therapeutic potential of miR-548d-3p mimics in osteosarcoma.

Main Methods:

  • Comparative analysis of miR-548d-3p expression in osteosarcoma tissues and cell lines versus normal controls.
  • Bioinformatic prediction and experimental validation of KRAS as a target gene for miR-548d-3p.
  • In vitro functional assays (cell growth, migration) using miR-548d-3p mimics in osteosarcoma cells.

Main Results:

  • Osteosarcoma tissues and cell lines showed significantly lower levels of miR-548d-3p compared to adjacent tissues and normal cell lines.
  • KRAS was confirmed as a direct target gene of miR-548d-3p.
  • Overexpression of miR-548d-3p (using mimics) led to a significant reduction in osteosarcoma cell proliferation and migration in vitro.

Conclusions:

  • miR-548d-3p functions as a tumor suppressor in osteosarcoma by downregulating KRAS.
  • miR-548d-3p mimics demonstrate potential as a novel therapeutic strategy for osteosarcoma treatment.
Keywords:
KRASgrowthmiR-548d-3pmigrationosteosarcoma

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.2K
Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells09:58

Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells

Published on: May 2, 2017

8.0K

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.8K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.6K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.0K